Journal of Materials Chemistry B,
Journal Year:
2024,
Volume and Issue:
13(1), P. 117 - 136
Published: Nov. 6, 2024
This
article
reviews
the
application
of
biomaterials
in
combination
with
immunotherapy
to
enhance
localized
treatment
tumors,
along
current
challenges
and
future
development
directions
this
field.
Angewandte Chemie International Edition,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 19, 2024
Abstract
Malignant
tumors
pose
a
significant
threat
to
global
public
health.
Promoting
programmed
cell
death
in
cancer
cells
has
become
critical
strategy
for
treatment.
PANoptosis,
newly
discovered
form
of
regulated
death,
integrates
key
molecular
components
pyroptosis,
apoptosis,
and
necroptosis,
activating
these
three
pathways
simultaneously
achieve
synergistic
multi‐mechanistic
killing.
PANoptosis
significantly
inhibits
growth
resistance
activates
strong
anti‐tumor
immune
response,
making
tumor‐specific
induction
potential
therapeutic
strategy.
Currently,
treatment
research
related
is
focused
mainly
on
the
development
small
molecules
cytokines.
However,
approaches
still
face
limitations
terms
metabolic
stability
tumor
specificity.
The
unique
physicochemical
properties
biological
activities
nanomaterials
hold
promise
optimizing
strategies.
This
review
summarizes
concept
mechanisms
highlights
latest
applications
nanoagents
PANoptosis‐based
anti‐cancer
therapy,
discusses
challenges
future
directions
clinical
translation.
It
hoped
that
this
will
inspire
further
exploration
treatments,
providing
new
perspectives
researchers
field.
Phenanthroline-type
ligand
containing
annealed
1,2,4-triazine
ring
was
used
to
prepare
novel
Ir(III)
complexes
3
and
4.
The
are
non-luminescent
but
show
luminogenic
behaviour
following
inverse
electron
demand
Diels-Alder
(IEDDA)
reaction
with
bicyclononyne
(BCN)
derivatives.
It
observed
that
the
complex
reacts
BCN-C10
three
times
faster
than
corresponding
free
7.
magnitude
of
this
accelerating
metal-coordination
effect,
however,
is
less
profound
in
previously
reported
1,2,4-triazines
which
triazine
directly
coordinated
metal
centre.
Nevertheless,
opens
prospects
for
use
such
bioimaging
applications,
demonstrated
by
developing
a
convenient
methodology
using
“chemistry
on
complex”
concept
labelling
antibodies
luminescent
complexes.
Bioorthogonal
reactivity
4
then
evaluated
metabolically
live
cells
BCN
groups
followed
IEDDA
iridium
complex.
Dalton Transactions,
Journal Year:
2024,
Volume and Issue:
53(37), P. 15501 - 15508
Published: Jan. 1, 2024
A
phenanthroline-type
ligand
containing
an
annealed
1,2,4-triazine
ring
was
used
to
prepare
novel
Ir(III)
complexes
3
and
4.
The
are
non-luminescent
but
show
luminogenic
behaviour
following
the
inverse
electron
demand
Diels-Alder
(IEDDA)
reaction
with
bicyclononyne
(BCN)
derivatives.
It
observed
that
react
BCN-C10
faster
than
corresponding
free
ligands.
magnitude
of
this
accelerating
metal-coordination
effect,
however,
is
less
profound
in
previously
reported
1,2,4-triazines,
which
triazine
directly
coordinated
metal
centre.
Nevertheless,
opens
prospects
for
use
such
bioimaging
applications,
demonstrated
by
developing
a
convenient
methodology
using
"chemistry
on
complex"
concept
labelling
antibodies
luminescent
complexes.
bioorthogonal
reactivity
complex
4
metabolically
live
cells
BCN
groups,
followed
IEDDA
iridium
complex.
Journal of Materials Chemistry B,
Journal Year:
2024,
Volume and Issue:
13(1), P. 117 - 136
Published: Nov. 6, 2024
This
article
reviews
the
application
of
biomaterials
in
combination
with
immunotherapy
to
enhance
localized
treatment
tumors,
along
current
challenges
and
future
development
directions
this
field.